FDA panel votes to keep severe warning on Pfizer anti-smoking drug

October 17, 2014 12:56 PM

4 0

FDA panel votes to keep severe warning on Pfizer anti-smoking drug

Pfizer Inc failed to convince the U.S. Food and Drug Administration to remove a black box warning on its controversial quit-smoking drug Chantix, with an advisory panel to the agency voting against the removal on Thursday.

A majority of the panel voted to keep the health regulator's most severe warning label on the treatment, in keeping with the recommendations of FDA staff two days earlier.

Read more

To category page

Loading...